APA

Zhou Q., Gustafson D., Nallapareddy S., Diab S., Leong S., Lewis K., Gore L., Messersmith W. A., Treston A. M., Eckhardt S. G., Sidor C. & Camidge D. R. (20110527). A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer. : Investigational new drugs.

Chicago

Zhou Qing, Gustafson Daniel, Nallapareddy Sujatha, Diab Sami, Leong Stephen, Lewis Karl, Gore Lia, Messersmith Wells A, Treston Anthony M, Eckhardt S Gail, Sidor Carolyn and Camidge D Ross. 20110527. A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer. : Investigational new drugs.

Harvard

Zhou Q., Gustafson D., Nallapareddy S., Diab S., Leong S., Lewis K., Gore L., Messersmith W. A., Treston A. M., Eckhardt S. G., Sidor C. and Camidge D. R. (20110527). A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer. : Investigational new drugs.

MLA

Zhou Qing, Gustafson Daniel, Nallapareddy Sujatha, Diab Sami, Leong Stephen, Lewis Karl, Gore Lia, Messersmith Wells A, Treston Anthony M, Eckhardt S Gail, Sidor Carolyn and Camidge D Ross. A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer. : Investigational new drugs. 20110527.